New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
2 hedge funds and large institutions have $9.56M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
190% more ownership
Funds ownership: 0% → 190% (+190%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSL
Mackay Shields LLC
New York
|
+$4.63M |
| 2 |
NYLIM
New York Life Investment Management
New York
|
+$4.63M |
Top Sellers
LRND Hedge Fund Activity: Q1 2022 in Review
2 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q1 2022, worth a combined $9.56M.
Buyers outnumbered sellers: 2 funds opened new LRND positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Mackay Shields LLC, opening a new position worth an estimated $4.63M.
- 2 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $9.56M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q1 2022.
- 2 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q1 2022 and 0 closed out, a net change of +2 holders.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF buyer in Q1 2022 was Mackay Shields LLC, an estimated $4.63M added.
Based on aggregated 13F filings for Q1 2022.